| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/2001 | EP1075518A2 Human transcriptional regulator molecules |
| 02/14/2001 | EP1075508A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075495A1 Gprw receptor |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075492A1 Melanocortin 1 receptor selective compounds |
| 02/14/2001 | EP1075491A2 Pth2 receptor selective compounds |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075488A1 Protein purification by ion exchange chromatography |
| 02/14/2001 | EP1075282A1 Peg-lhrh analog conjugates |
| 02/14/2001 | EP1075281A2 Polyol-ifn-beta conjugates |
| 02/14/2001 | EP1075280A2 Hemoglobine-haptoglobin complexes for targeted durg delivery |
| 02/14/2001 | EP1075277A2 Methods for detecting and inhibiting angiogenesis |
| 02/14/2001 | EP1075274A2 Immunomodulators for vaccines |
| 02/14/2001 | EP1075273A2 Inhibiton of helicobacter pylori proliferation |
| 02/14/2001 | EP1075272A1 Methods for treating diabetes by inhibiting gdf-8 |
| 02/14/2001 | EP1075271A2 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf) |
| 02/14/2001 | EP1075270A1 Short peptides for treatment of neurological degenerative diseases |
| 02/14/2001 | EP1075269A2 Anti-diarrheal and method for using the same |
| 02/14/2001 | EP1075266A1 Hematopoietic stimulation |
| 02/14/2001 | EP1075255A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
| 02/14/2001 | EP1003577A4 Blood product delivery system |
| 02/14/2001 | EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response |
| 02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 02/14/2001 | EP0799577B1 Peptide mixture and products thereof |
| 02/14/2001 | EP0738280B1 Superactive vip antagonists |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284086A Conjugates useful in treatment of prostate cancer |
| 02/14/2001 | CN1284084A Echinocandin derivatives, prepn. method and application as anti-fungal agents |
| 02/14/2001 | CN1284083A Tumor antigen peptide derivatives |
| 02/14/2001 | CN1284063A Compounds |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/14/2001 | CN1284058A Neuroprotective agents |
| 02/14/2001 | CN1283997A Keratinocyte growth factor-2 formulations |
| 02/14/2001 | CN1283695A Gene associated with esophagus cancer |
| 02/14/2001 | CN1283694A Gene associated with esophagus cancer |
| 02/14/2001 | CN1283693A Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 02/14/2001 | CN1283631A Gene recombination human platelet factor No.4 and its new usage |
| 02/14/2001 | CN1283629A Antineoplastic gancoderma mycelium-glucoprotein composition and its application and preparing process |
| 02/14/2001 | CN1283628A Extract of shark cartilage and its preparing process |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283508A Beautifying cosmetics series for treating red blood trace on face |
| 02/14/2001 | CN1283447A Locally-used weight reducing face-care compsns. |
| 02/14/2001 | CN1061992C Colony stimulating factor for recombination of human granulocytes and medicinal compsn thereof |
| 02/14/2001 | CN1061991C Schistosome vaccine peptide NO.3 |
| 02/14/2001 | CN1061990C Schistosome vaccine peptide No.1 |
| 02/13/2001 | USRE37053 Particles incorporating surfactants for pulmonary drug delivery |
| 02/13/2001 | US6187993 Transgenic animals as model of psoriasis |
| 02/13/2001 | US6187909 Amino acid sequences of receptor to neurologic regulators; antiinflammatory agents |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187906 Methods to improve neural outcome |
| 02/13/2001 | US6187905 Peptide compound which inhibits viral proteinases; viricides for hepatitis c, hepatitis g, and human gb viruses |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/13/2001 | US6187803 Treating allergic disease, autoimmune disease, immunodeficiency syndrome, inflammatory disease or eosinophilia by orally administering a histamine-added immunoglobulin and carrier; tablets, capsules |
| 02/13/2001 | US6187800 Method for the prevention and treatment of mastitis |
| 02/13/2001 | US6187771 Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/13/2001 | US6187756 Composition and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/13/2001 | US6187752 Method for treating schizophrenia employing an ace inhibitor |
| 02/13/2001 | US6187751 Biologically active peptide of ob protein |
| 02/13/2001 | US6187750 Administering human growth hormone |
| 02/13/2001 | US6187749 Methods for variation of chromatin condensation |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187746 Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof |
| 02/13/2001 | US6187745 Co-administration of a pentosan polysulfate (pps) or a pharmaceutically acceptable salt thereof. |
| 02/13/2001 | US6187744 Time-controlled superoxygenating compositions that comprise hemoglobin colloid and guanosine 3':5'-cyclic monophosphate (cyclic gmp) generating compounds |
| 02/13/2001 | US6187743 Composition and method for enhancing wound healing |
| 02/13/2001 | US6187742 Method for healing and repair of connective tissue attachment |
| 02/13/2001 | US6187593 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/13/2001 | US6187587 Nucleotide sequences; for diagnosis and treatment of related disorders |
| 02/13/2001 | US6187586 Nucleotide sequence of compound which inhibits expression of human serine/threonine kinase involved in signal transduction; diagnosis, prophylaxis, and therapy of related diseases |
| 02/13/2001 | US6187585 Oligonucleotide inhibition of epidermal growth factor receptor expression |
| 02/13/2001 | US6187572 Decontaminating blood and cell cultures by mixing with a chemical radiation sensitizer which does not bind to the membrane, freezing or freeze-drying the mixture, then exposing to electromagnetic radiation |
| 02/13/2001 | US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents |
| 02/13/2001 | US6187563 βIV-spectrin-polypeptides and nucleic acids encoding same |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187557 Nucleotide sequences coding modulator protein; for the diagnosis and treatment of defects in apotosis |
| 02/13/2001 | US6187553 Eliminating physiological effects of heparin in blood mixture in blood recovery tube; preparing mixture of heparinase, trehalose and buffer, spray coat wall of tube, dry, remove oxygen, stopper, irradiate, add blood and allow to coagulate |
| 02/13/2001 | US6187548 Detecting modulators of a human receptor polypeptide; expressing receptor polypeptide in cell, incubating modulator with cell expressing receptor polypeptide, monitor modulating activity |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187543 Method of screening a compound for its ability to enhance the ability of tristetraprolin to inhibit tumor necrosis factor |
| 02/13/2001 | US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders |
| 02/13/2001 | US6187345 Flutamide compositions and preparations |
| 02/13/2001 | US6187344 Powdered pharmaceutical formulations having improved dispersibility |
| 02/13/2001 | US6187334 Low methoxyl pectin, sodium alginates and acids, carrageenan and gellan gum |
| 02/13/2001 | US6187330 Local delivery of angiogenic amounts of basic fibroblast growth factor or vascular endothelial growth factor. |
| 02/13/2001 | US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication. |
| 02/13/2001 | US6187312 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases |
| 02/13/2001 | US6187311 Engineered acarid allergen and process for producing the same |
| 02/13/2001 | US6187308 Ameliorating an immune response disorder. |
| 02/13/2001 | US6187307 Cancer immunotherapy with semi-allogeneic cells |
| 02/13/2001 | US6187304 Effects of IFN-γ on cardiac hypertrophy |
| 02/13/2001 | US6187287 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells |
| 02/13/2001 | US6186148 Prevention of posterior capsular opacification |
| 02/13/2001 | CA2315588A1 Use of antithrombin iii for the prophylaxis and therapy of diseases |
| 02/13/2001 | CA2280314A1 Pulmonary surfactant formulation for instillation and for oral application |
| 02/13/2001 | CA2192674C Methods for treating respiratory disease |
| 02/13/2001 | CA2139358C Human growth hormone aqueous formulation |
| 02/13/2001 | CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |